PTD unknown

ovarian cancer breakthrough

  1. 286 Posts.
    In a study conducted at the Ovarian Cancer Research Foundation (OCRF) at Monash
    Medical Centre in Melbourne, an antibody detection method developed by Biosceptre
    successfully identified 100% of the invasive ovarian carcinomas (malignant cancers of
    the ovaries) included in the tissue analysis.
 
watchlist Created with Sketch. Add PTD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.